Virtu Financial LLC Edesa Biotech, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$2.72 - $5.97 $40,587 - $89,084	-14,922 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$5.17 - $8.65 $468,350 - $783,603	-90,590 Reduced 85.86%	14,922 $84,000
Q3 2021 Nov 12, 2021	BUY	$4.2 - $11.92 $363,610 - $1.03 Million	86,574 Added 457.14%	105,512 $779,000
Q2 2021 Sep 17, 2021	BUY	$4.93 - $6.69 $13,804 - $18,732	2,800 Added 17.35%	18,938 $100,000
Q1 2021 May 19, 2021	BUY	$4.3 - $7.48 $69,393 - $120,712	16,138 New	16,138 $87,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $33.6M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.